25 XP   0   0   10

Accelerate Diagnostics Inc
Buy, Hold or Sell?

Let's analyse Accelerate Diagnostics Inc together

PenkeI guess you are interested in Accelerate Diagnostics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Accelerate Diagnostics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Accelerate Diagnostics Inc

I send you an email if I find something interesting about Accelerate Diagnostics Inc.

Quick analysis of Accelerate Diagnostics Inc (30 sec.)










What can you expect buying and holding a share of Accelerate Diagnostics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$-0.92
Expected worth in 1 year
$-0.48
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$0.44
Return On Investment
47.4%

For what price can you sell your share?

Current Price per Share
$0.92
Expected price per share
$0.73 - $1.01
How sure are you?
50%

1. Valuation of Accelerate Diagnostics Inc (5 min.)




Live pricePrice per Share (EOD)

$0.92

Intrinsic Value Per Share

$-22.52 - $-6.78

Total Value Per Share

$-23.44 - $-7.69

2. Growth of Accelerate Diagnostics Inc (5 min.)




Is Accelerate Diagnostics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$19.8m-$22.2m$2.3m11.9%

How much money is Accelerate Diagnostics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$61.6m-$62.4m$875k1.4%
Net Profit Margin-511.0%-490.1%--

How much money comes from the company's main activities?

3. Financial Health of Accelerate Diagnostics Inc (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#323 / 332

Most Revenue
#228 / 332

Most Profit
#278 / 332

Most Efficient
#285 / 332

What can you expect buying and holding a share of Accelerate Diagnostics Inc? (5 min.)

Welcome investor! Accelerate Diagnostics Inc's management wants to use your money to grow the business. In return you get a share of Accelerate Diagnostics Inc.

What can you expect buying and holding a share of Accelerate Diagnostics Inc?

First you should know what it really means to hold a share of Accelerate Diagnostics Inc. And how you can make/lose money.

Speculation

The Price per Share of Accelerate Diagnostics Inc is $0.9248. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Accelerate Diagnostics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Accelerate Diagnostics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.92. Based on the TTM, the Book Value Change Per Share is $0.11 per quarter. Based on the YOY, the Book Value Change Per Share is $0.59 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Accelerate Diagnostics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.84-307.5%-2.84-307.5%-2.88-311.9%-3.36-363.7%-3.04-329.2%
Usd Book Value Change Per Share0.1111.9%0.1111.9%0.5963.9%-0.71-77.1%-0.28-30.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.3%0.000.2%
Usd Total Gains Per Share0.1111.9%0.1111.9%0.5963.9%-0.71-76.8%-0.28-30.5%
Usd Price Per Share3.92-3.92-0.71-6.87-13.35-
Price to Earnings Ratio-1.38--1.38--0.24--1.90--5.17-
Price-to-Total Gains Ratio35.74-35.74-1.19-6.47-5.76-
Price to Book Ratio-4.27--4.27--0.69--12.08--3.58-
Price-to-Total Gains Ratio35.74-35.74-1.19-6.47-5.76-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.9248
Number of shares1081
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.11-0.71
Usd Total Gains Per Share0.11-0.71
Gains per Quarter (1081 shares)118.56-767.79
Gains per Year (1081 shares)474.23-3,071.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1047446413-3084-3081
2094893826-6168-6152
301423141239-9253-9223
401897188652-12337-12294
502371236065-15421-15365
602845283478-18505-18436
703320330891-21589-21507
8037943782104-24673-24578
9042684256117-27758-27649
10047424730130-30842-30720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%5.023.00.017.9%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%6.04.00.060.0%13.015.00.046.4%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.09.010.0%3.00.025.010.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%6.04.00.060.0%14.014.00.050.0%

Fundamentals of Accelerate Diagnostics Inc

About Accelerate Diagnostics Inc

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Fundamental data was last updated by Penke on 2024-05-02 11:23:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Accelerate Diagnostics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Accelerate Diagnostics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • A Net Profit Margin of -511.0% means that $-5.11 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Accelerate Diagnostics Inc:

  • The MRQ is -511.0%. The company is making a huge loss. -2
  • The TTM is -511.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-511.0%TTM-511.0%0.0%
TTM-511.0%YOY-490.1%-20.9%
TTM-511.0%5Y-653.6%+142.6%
5Y-653.6%10Y-8,961.8%+8,308.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-511.0%-15.1%-495.9%
TTM-511.0%-20.4%-490.6%
YOY-490.1%-13.3%-476.8%
5Y-653.6%-20.4%-633.2%
10Y-8,961.8%-27.3%-8,934.5%
1.1.2. Return on Assets

Shows how efficient Accelerate Diagnostics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • -196.4% Return on Assets means that Accelerate Diagnostics Inc generated $-1.96 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Accelerate Diagnostics Inc:

  • The MRQ is -196.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -196.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-196.4%TTM-196.4%0.0%
TTM-196.4%YOY-96.1%-100.3%
TTM-196.4%5Y-106.5%-89.9%
5Y-106.5%10Y-78.7%-27.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-196.4%-4.0%-192.4%
TTM-196.4%-4.5%-191.9%
YOY-96.1%-4.3%-91.8%
5Y-106.5%-3.8%-102.7%
10Y-78.7%-4.8%-73.9%
1.1.3. Return on Equity

Shows how efficient Accelerate Diagnostics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • 0.0% Return on Equity means Accelerate Diagnostics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Accelerate Diagnostics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-37.3%+37.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.2%+4.2%
TTM--5.6%+5.6%
YOY--5.3%+5.3%
5Y--6.1%+6.1%
10Y-37.3%-6.7%-30.6%

1.2. Operating Efficiency of Accelerate Diagnostics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Accelerate Diagnostics Inc is operating .

  • Measures how much profit Accelerate Diagnostics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • An Operating Margin of -448.0% means the company generated $-4.48  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Accelerate Diagnostics Inc:

  • The MRQ is -448.0%. The company is operating very inefficient. -2
  • The TTM is -448.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-448.0%TTM-448.0%0.0%
TTM-448.0%YOY-492.5%+44.5%
TTM-448.0%5Y-580.4%+132.3%
5Y-580.4%10Y-8,940.3%+8,359.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-448.0%-24.6%-423.4%
TTM-448.0%-16.7%-431.3%
YOY-492.5%-12.3%-480.2%
5Y-580.4%-19.9%-560.5%
10Y-8,940.3%-25.7%-8,914.6%
1.2.2. Operating Ratio

Measures how efficient Accelerate Diagnostics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 5.48 means that the operating costs are $5.48 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 5.480. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.480. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.480TTM5.4800.000
TTM5.480YOY5.925-0.445
TTM5.4805Y6.804-1.323
5Y6.80410Y146.750-139.946
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4801.430+4.050
TTM5.4801.426+4.054
YOY5.9251.390+4.535
5Y6.8041.416+5.388
10Y146.7501.375+145.375

1.3. Liquidity of Accelerate Diagnostics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Accelerate Diagnostics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.03 means the company has $2.03 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 2.033. The company is able to pay all its short-term debts. +1
  • The TTM is 2.033. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.033TTM2.0330.000
TTM2.033YOY0.842+1.191
TTM2.0335Y8.025-5.992
5Y8.02510Y14.960-6.934
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0332.688-0.655
TTM2.0332.724-0.691
YOY0.8423.429-2.587
5Y8.0253.619+4.406
10Y14.9603.507+11.453
1.3.2. Quick Ratio

Measures if Accelerate Diagnostics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • A Quick Ratio of 1.41 means the company can pay off $1.41 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 1.406. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.406. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.406TTM1.4060.000
TTM1.406YOY0.881+0.525
TTM1.4065Y9.874-8.468
5Y9.87410Y20.190-10.316
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4061.521-0.115
TTM1.4061.671-0.265
YOY0.8812.113-1.232
5Y9.8742.316+7.558
10Y20.1902.425+17.765

1.4. Solvency of Accelerate Diagnostics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Accelerate Diagnostics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Accelerate Diagnostics Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 1.63 means that Accelerate Diagnostics Inc assets are financed with 163.4% credit (debt) and the remaining percentage (100% - 163.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 1.634. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.634. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.634TTM1.6340.000
TTM1.634YOY1.342+0.292
TTM1.6345Y1.425+0.209
5Y1.42510Y0.803+0.622
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6340.399+1.235
TTM1.6340.390+1.244
YOY1.3420.348+0.994
5Y1.4250.442+0.983
10Y0.8030.458+0.345
1.4.2. Debt to Equity Ratio

Measures if Accelerate Diagnostics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.246-0.246
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.576-0.576
TTM-0.562-0.562
YOY-0.497-0.497
5Y-0.626-0.626
10Y0.2460.696-0.450

2. Market Valuation of Accelerate Diagnostics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Accelerate Diagnostics Inc generates.

  • Above 15 is considered overpriced but always compare Accelerate Diagnostics Inc to the Medical Devices industry mean.
  • A PE ratio of -1.38 means the investor is paying $-1.38 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Accelerate Diagnostics Inc:

  • The EOD is -0.325. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.378. Based on the earnings, the company is expensive. -2
  • The TTM is -1.378. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.325MRQ-1.378+1.053
MRQ-1.378TTM-1.3780.000
TTM-1.378YOY-0.245-1.133
TTM-1.3785Y-1.904+0.526
5Y-1.90410Y-5.165+3.261
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.325-1.085+0.760
MRQ-1.378-1.794+0.416
TTM-1.378-2.279+0.901
YOY-0.245-2.674+2.429
5Y-1.904-2.530+0.626
10Y-5.165-2.057-3.108
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Accelerate Diagnostics Inc:

  • The EOD is -0.486. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.060. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.060. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.486MRQ-2.060+1.574
MRQ-2.060TTM-2.0600.000
TTM-2.060YOY-0.310-1.749
TTM-2.0605Y-2.705+0.645
5Y-2.70510Y-6.694+3.989
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.486-1.067+0.581
MRQ-2.060-1.662-0.398
TTM-2.060-3.006+0.946
YOY-0.310-6.187+5.877
5Y-2.705-4.921+2.216
10Y-6.694-5.292-1.402
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Accelerate Diagnostics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -4.27 means the investor is paying $-4.27 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Accelerate Diagnostics Inc:

  • The EOD is -1.007. Based on the equity, the company is expensive. -2
  • The MRQ is -4.270. Based on the equity, the company is expensive. -2
  • The TTM is -4.270. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.007MRQ-4.270+3.263
MRQ-4.270TTM-4.2700.000
TTM-4.270YOY-0.687-3.583
TTM-4.2705Y-12.083+7.813
5Y-12.08310Y-3.576-8.507
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.0071.999-3.006
MRQ-4.2702.384-6.654
TTM-4.2702.530-6.800
YOY-0.6873.169-3.856
5Y-12.0833.955-16.038
10Y-3.5764.369-7.945
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Accelerate Diagnostics Inc.

3.1. Institutions holding Accelerate Diagnostics Inc

Institutions are holding 12.824% of the shares of Accelerate Diagnostics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Hovey Youngman Associates Inc6.25110.1599135425413453011.0295
2023-12-31Vanguard Group Inc1.4154030663735681.1773
2023-09-30Alyeska Investment Group, L.P.0.57190.00481238981238980
2023-12-31Cannell Peter B & CO Inc0.52940.014311469000
2023-12-31Oracle Investment Management Inc0.5150.266111575-24953-18.2768
2023-12-31Geode Capital Management, LLC0.40160870032801947.5027
2023-12-31Tci Wealth Advisors Inc0.27090.02455868000
2023-12-31BlackRock Inc0.234705084200
2023-12-31Northern Trust Corp0.2129046119-3962-7.9112
2023-12-31Belpointe Asset Management LLC0.15730.011734080-64-0.1874
2023-12-31Cladis Investment Advisory LLC0.14630.112231700-4450-12.3098
2023-12-31State Street Corporation0.108602353500
2024-03-31Ironwood Wealth Management, LLC0.09150.004519813198130
2023-12-31Sonora Investment Management Group, LLC0.08310.005718000702864.054
2023-12-31Tudor Investment Corp Et AL0.06510.00051411400
2023-12-31Millennium Management LLC0.0644013947139470
2023-12-31Tejara Capital Ltd0.06280.02241361400
2023-12-31Thompson Investment Management LLC0.0480.006610390-1000-8.7796
2023-12-31UBS Group AG0.04609973489396.3189
2023-12-31Royal Bank of Canada0.04309315101312.2019
Total 11.3190.63312452179+302280+12.3%

3.2. Funds holding Accelerate Diagnostics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Vanguard Total Stock Mkt Idx Inv1.0314022345600
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr0.41670.0001902741322517.1644
2024-02-29Fidelity Extended Market Index0.25480.000155197-267-0.4814
2024-02-29BANOR SICAV Rosemary S EUR Acc0.0790.06241710900
2023-09-30BlackRock Extended Mkt Composite0.06150.000513330-1-0.0075
2024-03-31BlackRock Extended Equity Market K0.05370.00011163440.0344
2024-03-31Thompson MidCap0.0480.01831039000
2024-02-29Fidelity Series Total Market Index0.046201001500
2024-03-31NT Ext Equity Mkt Idx Fd - L0.0420.0001909300
2023-12-31Northern Trust Extended Eq Market Idx0.0420.00069093306850.9212
2024-02-29Fidelity Total Market Index0.04090885800
2024-02-29Fidelity Nasdaq Composite Index0.03850.0001834800
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.03150.0004682900
2024-03-31T. Rowe Price U.S. Equities Tr0.02950.0001639000
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.02530.00045485100.1826
2024-02-29Spartan Total Market Index Pool E0.02290495500
2024-02-29Spartan Extended Market Index Pool E0.00960.0001208226714.7107
2024-03-31Extended Equity Market Fund M0.00660.00011435-3-0.2086
2024-03-31Vanguard U.S. Eq Idx £ Acc0.0060130400
2023-12-31SSgA U.S. Extended Market Index Class I0.00410.000188600
Total 2.29020.0835496163+16303+3.3%

3.3. Insider Transactions

Insiders are holding 37.112% of the shares of Accelerate Diagnostics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-17Jack PhillipsSELL267350.78
2024-04-12Jack PhillipsSELL265450.86
2024-04-09David PatienceSELL132960.87
2024-04-09Larry Michael MertzSELL139840.87
2024-04-04Jack PhillipsSELL158870.88
2024-04-04Larry Michael MertzSELL9780.88
2024-02-26David PatienceSELL3500.96
2024-02-01Jack PhillipsSELL4941.3
2023-12-13David PatienceSELL974.39
2023-12-13Jack PhillipsSELL7394.39
2023-10-13David PatienceSELL965.83
2023-10-13Jack PhillipsSELL7345.83
2023-09-13David PatienceSELL966.53
2023-09-13Jack PhillipsSELL7336.53
2023-08-14David PatienceSELL956.8
2023-08-14Jack PhillipsSELL7516.8
2023-07-13David PatienceSELL926.9
2023-07-13Jack PhillipsSELL7296.9
2023-06-22Jack PhillipsSELL27267.1
2023-06-13David PatienceSELL1289

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Accelerate Diagnostics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1100.1100%0.591-81%-0.713+750%-0.283+358%
Book Value Per Share---0.918-0.9180%-1.028+12%-1.361+48%1.416-165%
Current Ratio--2.0332.0330%0.842+142%8.025-75%14.960-86%
Debt To Asset Ratio--1.6341.6340%1.342+22%1.425+15%0.803+103%
Debt To Equity Ratio----0%-0%-0%0.246-100%
Dividend Per Share----0%-0%0.003-100%0.002-100%
Eps---2.844-2.8440%-2.885+1%-3.363+18%-3.044+7%
Free Cash Flow Per Share---1.903-1.9030%-2.275+20%-2.357+24%-2.299+21%
Free Cash Flow To Equity Per Share---1.487-1.4870%-0.815-45%-1.412-5%-0.126-92%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---6.777--------
Intrinsic Value_10Y_min---22.522--------
Intrinsic Value_1Y_max---1.821--------
Intrinsic Value_1Y_min---2.356--------
Intrinsic Value_3Y_max---4.602--------
Intrinsic Value_3Y_min---7.034--------
Intrinsic Value_5Y_max---6.333--------
Intrinsic Value_5Y_min---11.629--------
Market Cap20035237.120-324%84924448.00084924448.0000%15295066.400+455%148730438.880-43%289124416.640-71%
Net Profit Margin---5.110-5.1100%-4.901-4%-6.536+28%-89.618+1654%
Operating Margin---4.480-4.4800%-4.925+10%-5.804+30%-89.403+1895%
Operating Ratio--5.4805.4800%5.925-8%6.804-19%146.750-96%
Pb Ratio-1.007+76%-4.270-4.2700%-0.687-84%-12.083+183%-3.576-16%
Pe Ratio-0.325+76%-1.378-1.3780%-0.245-82%-1.904+38%-5.165+275%
Price Per Share0.925-324%3.9203.9200%0.706+455%6.865-43%13.346-71%
Price To Free Cash Flow Ratio-0.486+76%-2.060-2.0600%-0.310-85%-2.705+31%-6.694+225%
Price To Total Gains Ratio8.432-324%35.74335.7430%1.194+2893%6.470+452%5.764+520%
Quick Ratio--1.4061.4060%0.881+60%9.874-86%20.190-93%
Return On Assets---1.964-1.9640%-0.961-51%-1.065-46%-0.787-60%
Return On Equity----0%-0%-0%-0.3730%
Total Gains Per Share--0.1100.1100%0.591-81%-0.710+748%-0.282+357%
Usd Book Value---19888000.000-19888000.0000%-22264000.000+12%-29482800.000+48%30670600.000-165%
Usd Book Value Change Per Share--0.1100.1100%0.591-81%-0.713+750%-0.283+358%
Usd Book Value Per Share---0.918-0.9180%-1.028+12%-1.361+48%1.416-165%
Usd Dividend Per Share----0%-0%0.003-100%0.002-100%
Usd Eps---2.844-2.8440%-2.885+1%-3.363+18%-3.044+7%
Usd Free Cash Flow---41230999.000-41230999.0000%-49282000.000+20%-51063799.800+24%-49810199.900+21%
Usd Free Cash Flow Per Share---1.903-1.9030%-2.275+20%-2.357+24%-2.299+21%
Usd Free Cash Flow To Equity Per Share---1.487-1.4870%-0.815-45%-1.412-5%-0.126-92%
Usd Market Cap20035237.120-324%84924448.00084924448.0000%15295066.400+455%148730438.880-43%289124416.640-71%
Usd Price Per Share0.925-324%3.9203.9200%0.706+455%6.865-43%13.346-71%
Usd Profit---61618000.000-61618000.0000%-62493000.000+1%-72865200.000+18%-65833900.000+7%
Usd Revenue--12059000.00012059000.0000%12752000.000-5%11411000.000+6%6741700.000+79%
Usd Total Gains Per Share--0.1100.1100%0.591-81%-0.710+748%-0.282+357%
 EOD+1 -7MRQTTM+0 -0YOY+20 -115Y+19 -1410Y+18 -16

4.2. Fundamental Score

Let's check the fundamental score of Accelerate Diagnostics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.325
Price to Book Ratio (EOD)Between0-1-1.007
Net Profit Margin (MRQ)Greater than0-5.110
Operating Margin (MRQ)Greater than0-4.480
Quick Ratio (MRQ)Greater than11.406
Current Ratio (MRQ)Greater than12.033
Debt to Asset Ratio (MRQ)Less than11.634
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.964
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Accelerate Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.388
Ma 20Greater thanMa 500.890
Ma 50Greater thanMa 1000.949
Ma 100Greater thanMa 2001.795
OpenGreater thanClose0.920
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets31,366
Total Liabilities51,254
Total Stockholder Equity-19,888
 As reported
Total Liabilities 51,254
Total Stockholder Equity+ -19,888
Total Assets = 31,366

Assets

Total Assets31,366
Total Current Assets24,466
Long-term Assets6,900
Total Current Assets
Cash And Cash Equivalents 12,138
Short-term Investments 1,081
Net Receivables 2,622
Inventory 3,310
Other Current Assets 5,315
Total Current Assets  (as reported)24,466
Total Current Assets  (calculated)24,466
+/-0
Long-term Assets
Property Plant Equipment 5,084
Long-term Assets Other 1,816
Long-term Assets  (as reported)6,900
Long-term Assets  (calculated)6,900
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,034
Long-term Liabilities39,220
Total Stockholder Equity-19,888
Total Current Liabilities
Short-term Debt 2,286
Short Long Term Debt 726
Accounts payable 4,796
Other Current Liabilities 3,407
Total Current Liabilities  (as reported)12,034
Total Current Liabilities  (calculated)11,215
+/- 819
Long-term Liabilities
Long term Debt 36,102
Capital Lease Obligations 2,392
Long-term Liabilities Other 1,164
Long-term Liabilities  (as reported)39,220
Long-term Liabilities  (calculated)39,658
+/- 438
Total Stockholder Equity
Common Stock14
Retained Earnings -668,857
Accumulated Other Comprehensive Income -612
Other Stockholders Equity 649,567
Total Stockholder Equity (as reported)-19,888
Total Stockholder Equity (calculated)-19,888
+/-0
Other
Capital Stock14
Cash and Short Term Investments 13,219
Common Stock Shares Outstanding 12,477
Current Deferred Revenue1,545
Liabilities and Stockholders Equity 31,366
Net Debt 27,082
Net Invested Capital 16,940
Net Working Capital 12,432
Property Plant and Equipment Gross 16,095
Short Long Term Debt Total 39,220



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-31
> Total Assets 
2,300
9,800
13,975
14,073
13,106
10,732
15,024
13,745
12,725
11,008
7,848
6,138
5,827
5,231
6,269
6,264
17,214
43,430
69,801
139,324
82,852
126,727
185,265
134,424
93,425
83,047
65,015
31,366
31,36665,01583,04793,425134,424185,265126,72782,852139,32469,80143,43017,2146,2646,2695,2315,8276,1387,84811,00812,72513,74515,02410,73213,10614,07313,9759,8002,300
   > Total Current Assets 
2,000
9,000
12,026
11,658
11,123
9,652
9,879
8,773
7,504
6,131
3,084
1,532
1,376
943
751
1,423
15,042
42,143
67,098
134,151
78,448
120,487
177,640
121,852
81,987
73,331
56,014
24,466
24,46656,01473,33181,987121,852177,640120,48778,448134,15167,09842,14315,0421,4237519431,3761,5323,0846,1317,5048,7739,8799,65211,12311,65812,0269,0002,000
       Cash And Cash Equivalents 
1,400
7,900
10,439
10,257
10,360
9,522
8,631
8,712
7,233
5,564
3,004
1,394
1,233
862
283
776
14,263
30,029
53,563
120,585
19,244
28,513
66,260
61,014
35,781
39,898
34,905
12,138
12,13834,90539,89835,78161,01466,26028,51319,244120,58553,56330,02914,2637762838621,2331,3943,0045,5647,2338,7128,6319,52210,36010,25710,4397,9001,400
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,959
13,115
11,839
58,519
80,648
100,218
47,437
32,488
23,720
10,656
1,081
1,08110,65623,72032,48847,437100,21880,64858,51911,83913,11511,95900000000000000000
       Net Receivables 
400
900
1,415
1,122
277
69
1,186
6
199
311
11
6
6
0
416
596
751
24
78
77
34
1,946
1,860
3,222
1,550
2,320
2,416
2,622
2,6222,4162,3201,5503,2221,8601,946347778247515964160661131119961,186692771,1221,415900400
       Other Current Assets 
200
200
171
279
486
61
62
55
7
228
43
24
39
28
19
21
18
130
342
12
183
467
576
1,165
1,780
1,558
2,025
5,315
5,3152,0251,5581,7801,16557646718312342130182119283924432287556261486279171200200
   > Long-term Assets 
300
800
1,949
2,414
1,983
1,079
5,145
4,972
5,221
4,877
4,764
4,606
4,451
4,288
5,518
4,841
2,171
1,287
2,703
5,173
4,404
6,240
7,625
12,572
11,438
9,716
9,001
6,900
6,9009,0019,71611,43812,5727,6256,2404,4045,1732,7031,2872,1714,8415,5184,2884,4514,6064,7644,8775,2214,9725,1451,0791,9832,4141,949800300
       Property Plant Equipment 
100
200
293
258
180
82
77
142
217
231
180
107
37
15
4
4
4
1,047
2,536
5,016
4,258
4,890
7,303
11,822
9,318
7,899
7,759
5,084
5,0847,7597,8999,31811,8227,3034,8904,2585,0162,5361,04744415371071802312171427782180258293200100
       Goodwill 
0
0
0
0
0
0
4,623
4,256
4,071
3,879
3,712
3,472
3,347
3,170
2,968
2,788
300
241
167
157
146
134
114
0
0
0
0
0
000001141341461571672413002,7882,9683,1703,3473,4723,7123,8794,0714,2564,623000000
       Intangible Assets 
0
0
0
0
0
485
4,623
4,256
4,071
3,879
3,712
3,472
3,347
3,169
2,967
2,787
681
241
167
157
146
134
114
0
0
0
0
0
000001141341461571672416812,7872,9673,1693,3473,4723,7123,8794,0714,2564,62348500000
       Long-term Assets Other 
200
600
1,656
2,156
1,802
997
445
574
933
768
871
1,028
1,067
3,170
1,337
745
-900
0
0
0
4,404
1,216
208
750
-5,857
1,817
1,242
1,816
1,8161,2421,817-5,8577502081,2164,404000-9007451,3373,1701,0671,0288717689335744459971,8022,1561,656600200
> Total Liabilities 
400
600
1,619
1,837
1,844
1,120
1,279
1,016
988
1,340
1,109
1,258
1,414
1,337
1,359
1,449
2,378
1,914
3,810
6,306
5,036
6,807
127,890
141,803
156,237
118,118
87,279
51,254
51,25487,279118,118156,237141,803127,8906,8075,0366,3063,8101,9142,3781,4491,3591,3371,4141,2581,1091,3409881,0161,2791,1201,8441,8371,619600400
   > Total Current Liabilities 
300
400
790
691
623
527
734
367
247
497
162
155
272
158
76
69
1,392
1,137
2,783
5,306
4,036
6,786
7,763
8,162
6,969
6,945
66,557
12,034
12,03466,5576,9456,9698,1627,7636,7864,0365,3062,7831,1371,3926976158272155162497247367734527623691790400300
       Short-term Debt 
0
0
0
0
0
0
0
0
47
0
0
0
0
0
0
0
0
0
147
13
0
0
0
450
1,050
749
58,355
2,286
2,28658,3557491,050450000131470000000004700000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160
13
0
0
0
0
553
80
56,413
726
72656,41380553000013160000000000000000000
       Accounts payable 
100
100
402
223
184
153
88
177
97
153
72
65
134
39
32
35
63
540
2,129
2,623
992
2,080
1,322
2,351
1,290
1,983
4,501
4,796
4,7964,5011,9831,2902,3511,3222,0809922,6232,1295406335323913465721539717788153184223402100100
       Other Current Liabilities 
200
300
388
61
130
220
479
39
90
279
31
32
26
26
23
25
1,243
515
988
5,086
3,009
3,636
6,224
5,090
4,253
3,762
3,154
3,407
3,4073,1543,7624,2535,0906,2243,6363,0095,0869885151,243252326263231279903947922013061388300200
   > Long-term Liabilities 
100
200
829
1,146
1,221
593
545
649
741
843
946
1,103
1,142
1,179
1,284
1,380
986
777
1,027
1,000
1,000
21
120,127
133,641
149,268
111,173
20,722
39,220
39,22020,722111,173149,268133,641120,127211,0001,0001,0277779861,3801,2841,1791,1421,1039468437416495455931,2211,146829200100
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
0
0
0
120,074
130,043
145,870
107,984
0
0
00107,984145,870130,043120,07400013000000000000000000
       Other Liabilities 
0
0
0
0
811
587
520
649
741
843
947
1,103
1,142
1,179
1,283
1,380
986
776
1,014
1,000
1,000
21
53
19
335
808
1,537
0
01,5378083351953211,0001,0001,0147769861,3801,2831,1791,1421,1039478437416495205878110000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
0
0
0
0
0
0
0
00000001,00000000000000000000000
> Total Stockholder Equity
1,900
9,200
12,356
12,236
11,262
9,611
13,745
12,729
11,737
9,668
6,739
4,880
4,413
3,894
4,910
4,815
14,836
41,517
65,991
133,018
77,816
119,920
57,375
-7,379
-62,812
-35,071
-22,264
-19,888
-19,888-22,264-35,071-62,812-7,37957,375119,92077,816133,01865,99141,51714,8364,8154,9103,8944,4134,8806,7399,66811,73712,72913,7459,61111,26212,23612,3569,2001,900
   Common Stock
0
0
8,543
8,353
8,302
8,198
12,342
12,488
12,863
12,863
12,878
12,878
13,804
13,804
14,139
14,333
22,986
42
45
51
52
56
54
55
58
68
97
14
149768585554565251454222,98614,33314,13913,80413,80412,87812,87812,86312,86312,48812,3428,1988,3028,3538,54300
   Retained Earnings 
-100
900
3,771
3,841
2,919
1,372
971
-404
-1,314
-3,405
-6,435
-8,359
-10,040
-10,754
-10,112
-10,491
-15,802
-34,484
-65,417
-110,915
-177,289
-240,825
-330,348
-414,653
-492,966
-570,668
-607,239
-668,857
-668,857-607,239-570,668-492,966-414,653-330,348-240,825-177,289-110,915-65,417-34,484-15,802-10,491-10,112-10,754-10,040-8,359-6,435-3,405-1,314-4049711,3722,9193,8413,771900-100
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,925
75,937
131,356
243,894
255,257
360,620
432,885
452,344
475,072
580,652
0
0
00580,652475,072452,344432,885360,620255,257243,894131,35675,9377,9250000000000000000
   Treasury Stock00-45,067-45,067-45,067-45,06700000-274-274-274-274-274-274-274-274-274-274-273-274-2740000
   Other Stockholders Equity 
2,000
8,300
315
41
41
41
56
271
187
210
13,448
13,513
14,726
14,649
15,022
15,307
7,651
75,937
131,356
243,894
255,257
360,620
387,818
407,277
430,005
535,585
585,274
649,567
649,567585,274535,585430,005407,277387,818360,620255,257243,894131,35675,9377,65115,30715,02214,64914,72613,51313,448210187271564141413158,3002,000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue12,059
Cost of Revenue-9,509
Gross Profit2,5502,550
 
Operating Income (+$)
Gross Profit2,550
Operating Expense-56,578
Operating Income-54,028-54,028
 
Operating Expense (+$)
Research Development25,353
Selling General Administrative34,203
Selling And Marketing Expenses0
Operating Expense56,57859,556
 
Net Interest Income (+$)
Interest Income1,321
Interest Expense-7,743
Other Finance Cost-685
Net Interest Income-5,737
 
Pretax Income (+$)
Operating Income-54,028
Net Interest Income-5,737
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-60,768-47,288
EBIT - interestExpense = -61,771
-60,768
-53,875
Interest Expense7,743
Earnings Before Interest and Taxes (EBIT)-54,028-53,025
Earnings Before Interest and Taxes (EBITDA)-50,774
 
After tax Income (+$)
Income Before Tax-60,768
Tax Provision-209
Net Income From Continuing Ops-63,229-60,977
Net Income-61,618
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses66,087
Total Other Income/Expenses Net-6,7405,737
 

Technical Analysis of Accelerate Diagnostics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Accelerate Diagnostics Inc. The general trend of Accelerate Diagnostics Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Accelerate Diagnostics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Accelerate Diagnostics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.9497 < 0.95 < 1.01.

The bearish price targets are: 0.73.

Tweet this
Accelerate Diagnostics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Accelerate Diagnostics Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Accelerate Diagnostics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Accelerate Diagnostics Inc. The current macd is -0.01457691.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Accelerate Diagnostics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Accelerate Diagnostics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Accelerate Diagnostics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Accelerate Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAccelerate Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Accelerate Diagnostics Inc. The current adx is 17.67.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Accelerate Diagnostics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Accelerate Diagnostics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Accelerate Diagnostics Inc. The current sar is 0.77178635.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Accelerate Diagnostics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Accelerate Diagnostics Inc. The current rsi is 49.39. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Accelerate Diagnostics Inc Daily Relative Strength Index (RSI) ChartAccelerate Diagnostics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Accelerate Diagnostics Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Accelerate Diagnostics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Accelerate Diagnostics Inc Daily Stochastic Oscillator ChartAccelerate Diagnostics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Accelerate Diagnostics Inc. The current cci is 95.60.

Accelerate Diagnostics Inc Daily Commodity Channel Index (CCI) ChartAccelerate Diagnostics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Accelerate Diagnostics Inc. The current cmo is 5.42056422.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Accelerate Diagnostics Inc Daily Chande Momentum Oscillator (CMO) ChartAccelerate Diagnostics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Accelerate Diagnostics Inc. The current willr is -30.42857143.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Accelerate Diagnostics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Accelerate Diagnostics Inc Daily Williams %R ChartAccelerate Diagnostics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Accelerate Diagnostics Inc. The current atr is 0.07841394.

Accelerate Diagnostics Inc Daily Average True Range (ATR) ChartAccelerate Diagnostics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Accelerate Diagnostics Inc. The current obv is 13,522,995.

Accelerate Diagnostics Inc Daily On-Balance Volume (OBV) ChartAccelerate Diagnostics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Accelerate Diagnostics Inc. The current mfi is 57.48.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Accelerate Diagnostics Inc Daily Money Flow Index (MFI) ChartAccelerate Diagnostics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Accelerate Diagnostics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Accelerate Diagnostics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Accelerate Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.388
Ma 20Greater thanMa 500.890
Ma 50Greater thanMa 1000.949
Ma 100Greater thanMa 2001.795
OpenGreater thanClose0.920
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Accelerate Diagnostics Inc with someone you think should read this too:
  • Are you bullish or bearish on Accelerate Diagnostics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Accelerate Diagnostics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Accelerate Diagnostics Inc

I send you an email if I find something interesting about Accelerate Diagnostics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Accelerate Diagnostics Inc.

Receive notifications about Accelerate Diagnostics Inc in your mailbox!